Log in | Register

What’s new in invasive pulmonary aspergillosis in the critically ill

Despoina Koulenti| Dirk Vogelaers| Stijn Blot
What's New in Intensive Care
Volume 40, Issue 5 / May , 2014

Pages 723 - 726

No abstract available.

References

  1. Koulenti D, Garnacho-Montero J, Blot S (2014) Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis 27(2):174–183
  2. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821
    • View reference on PubMed
    • View reference on publisher's website
  3. Baddley JW, Stephens JM, Ji X, Gao X, Schlamm HT, Tarallo M (2013) Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes. BMC Infect Dis 13:29
    • View reference on PubMed
    • View reference on publisher's website
  4. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, Lagrou K, Wilmer A, Jorens P, Hermans G (2012) Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 38:1761–1768
  5. Vandewoude K, Blot S, Benoit D, Depuydt P, Vogelaers D, Colardyn F (2004) Invasive aspergillosis in ICU patients: analysis of risk factors for acquisition and mortality. Acta Clin Belg 59:251–257
    • View reference on PubMed
    • View reference on publisher's website
  6. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R (2008) Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47:1176–1184
    • View reference on PubMed
    • View reference on publisher's website
  7. Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, Vandewoude K, Vogelaers D (2012) A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 186:56–64
    • View reference on PubMed
    • View reference on publisher's website
  8. Vandewoude KH, Blot SI, Depuydt P, Benoit D, Temmerman W, Colardyn F, Vogelaers D (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31
    • View reference on PubMed
    • View reference on publisher's website
  9. Blot S, Charles PE (2013) Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome. Minerva Anestesiol 79:1396–1405
    • View reference on PubMed
  10. Steinbach WJ (2013) Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of Aspergillus fumigatus and invasive aspergillosis. PLoS Pathog 9:e1003642
    • View reference on PubMed
    • View reference on publisher's website
  11. Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S, Spriet I, Verbeken E, VanWijngaerden E (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177:27–34
    • View reference on PubMed
    • View reference on publisher's website
  12. Acosta J, Catalan M, del Palacio-Perez-Medel A, Lora D, Montejo JC, Cuetara MS, Moragues MD, Ponton J, del Palacio A (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-beta-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 17:1053–1060
    • View reference on PubMed
    • View reference on publisher's website
  13. He H, Ding L, Sun B, Li F, Zhan Q (2012) Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study. Crit Care 16:R138
    • View reference on PubMed
    • View reference on publisher's website
  14. Acosta J, Catalan M, del Palacio-Pérez-Medel A, Montejo JC, De-La-Cruz-Bértolo J, Moragues MD, Pontón J, Finkelman MA, del Palacio A (2012) Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-d-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease. Eur J Clin Microbiol Infect Dis 31:721–731
    • View reference on PubMed
    • View reference on publisher's website
  15. Park WB, Kim NH, Kim KH, Lee SH, Nam WS, Yoon SH, Song KH, Choe PG, Kim NJ, Jang IJ, Oh MD, Yu KS (2012) The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis 55:1080–1087
    • View reference on PubMed
    • View reference on publisher's website
  16. Ben-Ami R (2013) Angiogenesis at the mold–host interface: a potential key to understanding and treating invasive aspergillosis. Future Microbiol 8:1453–1462
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement